share_log

Needham Maintains Buy on Veracyte, Raises Price Target to $35

Benzinga ·  Aug 9, 2023 06:10

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $34 to $35.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment